Shares & Derivatives
Illumina (ILMN) – Part 2
By Singaporean Talks Money  •  July 5, 2020
Illumina is a company specialising in genomics and strives to allow customers to read and understand genetic variations. They help provide research and also clinical services to customers. I would say that it is a pretty niche industry where R&D really plays a huge part in the company's development. Business Model Their business mainly consist of 2 genomic technologies, sequencing and microarrays. Sequencing which is a more deep analysis of genomes and targeted DNA region is not fully known while microarrays are for discovery in common variations and when quick answers are required. Sequencing accounts for about 88% of the revenue while microarrays account for about 12% of it's revenue. Financials Gross profit and revenue was good in first 3 months of 2020 but net income drops compared to 2019 as total operating expense increases. Free cash flow is also looking good. Overall outlook and my opinions Overall, for me, genomics and DNA is really such a niche industry...
Read the full article
By Singaporean Talks Money
I am currently a 23 year old university student in SIM. I hope to be able to grow my money and see the power of compound interest. I became interested in investing when I took a gap year and worked full-time. I realized that by just saving, it was very difficult to achieve my financial goals hence i read up on investing.
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance